News Website

Unmet Needs and Gaps in Treatment Options for Advanced EC Post-IO Therapy - OncLive

Unmet Needs and Gaps in Treatment Options for Advanced EC Post-IO Therapy OncLive

Published: May 5, 2025, 12:35 p.m.

Read Full Article

Watch 9News Latest Stories - Season 2025 - New therapy combating high cholesterol - 9Now

Watch 9News Latest Stories - Season 2025 - New therapy combating high cholesterol 9Now

Published: May 2, 2025, 9:37 a.m.

Read Full Article

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort - BioSpace

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort BioSpace

Published: April 30, 2025, 5:52 a.m.

Read Full Article

Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma - OncLive

Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma OncLive

Published: April 28, 2025, 1:18 p.m.

Read Full Article

Comprehensive single-cell transcriptome analysis of autologous platelet-rich plasma therapy on human thin endometrium - Nature

Comprehensive single-cell transcriptome analysis of autologous platelet-rich plasma therapy on human thin endometrium Nature

Published: April 26, 2025, 9:58 a.m.

Read Full Article

A Dual-Interaction Supramolecular Hydrogel System for siRNA Delivery to Enhance Endometrial Receptivity in Stem Cell Therapy - ACS Publications

A Dual-Interaction Supramolecular Hydrogel System for siRNA Delivery to Enhance Endometrial Receptivity in Stem Cell Therapy ACS Publications

Published: April 25, 2025, 11:16 p.m.

Read Full Article

Dr Agustí Garcia on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer - OncLive

Dr Agustí Garcia on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer OncLive

Published: April 21, 2025, 7:21 p.m.

Read Full Article

Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer - OncLive

Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer OncLive

Published: April 21, 2025, 1:17 p.m.

Read Full Article

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.

Read Full Article

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.

Read Full Article

Latest Articles

Unmet Needs and Gaps in Treatment Options for Advanced EC Post-IO Therapy - OncLive

Watch 9News Latest Stories - Season 2025 - New therapy combating high cholesterol - 9Now

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort - BioSpace

Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma - OncLive

Comprehensive single-cell transcriptome analysis of autologous platelet-rich plasma therapy on human thin endometrium - Nature

A Dual-Interaction Supramolecular Hydrogel System for siRNA Delivery to Enhance Endometrial Receptivity in Stem Cell Therapy - ACS Publications

Dr Agustí Garcia on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer - OncLive

Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer - OncLive

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Subscribe to Our Newsletter